Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
Boulder Care · with National Institute on Drug Abuse (NIDA) · NCT07169409
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 1
- Target enrollment
- 250
- US sites recruiting
- 1
- Study start
- June 10, 2025
- Record last updated
- September 11, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment as well as business profitability.
Being studied: Telemedicine Buprenorphine Treatment
Conditions: Opioid Use Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- History of Opioid Use Disorder (OUD)
- Starting OUD treatment with buprenorphine, or within 45 days of starting or restarting this medication
- Speak and understand English
Exclusion Criteria
- History of allergic reaction to buprenorphine
- Plans to move out of a Boulder Care-affiliated state site in the next 12 months (precluding continuation of care)
- Untreated mental or medical health conditions that, in the opinion of the participant, would preclude study participation
Recruiting US locations
Boulder Care
Portland, OR 97204
Site contact: Andrea Baron, MPH · 4084832766 · andrea.baron@boulder.care
Study contacts (from the official record)
- Andrea Baron, MPH · 408-483-2766 · andrea.baron@boulder.care
- Laura Monico, PhD · 855-605-8816 · laura.monico@boulder.care
Similar studies in Oregon
All phase 1 studies in Oregon →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Bend, OR + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1/Phase 2
Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 20–49
- RecruitingHealthy volunteersEarly Phase 1
Monoferric for Prenatal Iron Deficiency
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 18–65 · Women only
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- Portland, OR + 9 other US sites
- Eligibility basics
- Ages 6 mo–17